Zoetis Inc (ZTS)
153.42
+2.54
(+1.68%)
USD |
NYSE |
Apr 25, 16:00
153.53
+0.11
(+0.07%)
After-Hours: 16:42
Zoetis Cash from Investing (TTM): -777.00M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -777.00M |
| September 30, 2023 | -1.005B |
| June 30, 2023 | -858.00M |
| March 31, 2023 | -981.00M |
| December 31, 2022 | -883.00M |
| September 30, 2022 | -587.00M |
| June 30, 2022 | -577.00M |
| March 31, 2022 | -513.00M |
| December 31, 2021 | -458.00M |
| September 30, 2021 | -493.00M |
| June 30, 2021 | -553.00M |
| March 31, 2021 | -578.00M |
| December 31, 2020 | -572.00M |
| September 30, 2020 | -608.00M |
| June 30, 2020 | -643.00M |
| March 31, 2020 | -538.00M |
| December 31, 2019 | -504.00M |
| September 30, 2019 | -365.00M |
| June 30, 2019 | -2.22B |
| March 31, 2019 | -2.237B |
| December 31, 2018 | -2.259B |
| September 30, 2018 | -2.239B |
| June 30, 2018 | -303.00M |
| March 31, 2018 | -267.00M |
| December 31, 2017 | -270.00M |
| Date | Value |
|---|---|
| September 30, 2017 | -275.00M |
| June 30, 2017 | -271.00M |
| March 31, 2017 | -280.00M |
| December 31, 2016 | -214.00M |
| September 30, 2016 | -892.00M |
| June 30, 2016 | -828.00M |
| March 31, 2016 | -823.00M |
| December 31, 2015 | -1.115B |
| September 30, 2015 | -428.00M |
| June 30, 2015 | -410.00M |
| March 31, 2015 | -416.00M |
| December 31, 2014 | -187.00M |
| September 30, 2014 | -188.00M |
| June 30, 2014 | -200.00M |
| March 31, 2014 | -202.00M |
| December 31, 2013 | -179.00M |
| September 30, 2013 | -174.00M |
| June 30, 2013 | -150.00M |
| March 31, 2013 | -124.00M |
| December 31, 2012 | -135.00M |
| September 30, 2012 | -115.00M |
| June 30, 2012 | -105.00M |
| March 31, 2012 | -103.00M |
| December 31, 2011 | -449.00M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-2.22B
Minimum
Jun 2019
-365.00M
Maximum
Sep 2019
-721.74M
Average
-578.00M
Median
Mar 2021
Cash from Investing (TTM) Benchmarks
| Biogen Inc | -4.101B |
| Eli Lilly and Co | -7.153B |
| Pfizer Inc | -32.28B |
| Abbott Laboratories | -3.133B |
| Bristol-Myers Squibb Co | -2.295B |